IDEAYA Biosciences
IDYA
253 hedge funds and large institutions have $3.16B invested in IDEAYA Biosciences in 2026 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 32 closing their positions.
41% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 32
20% more call options, than puts
Call options by funds: $46.7M | Put options by funds: $39M
16% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 75
3% more funds holding
Funds holding: 246 → 253 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less capital invested
Capital invested by funds: $3.32B → $3.16B (-$159M)
1.58% less ownership
Funds ownership: 109.41% → 107.83% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$20.4M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.3M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
+$13.5M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$13.2M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$50.9M |
| 2 |
DM
Deerfield Management
New York
|
-$20.9M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.7M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$13M |
| 5 |
State Street
Boston,
Massachusetts
|
-$11.9M |
IDYA Hedge Fund Activity: Q1 2026 in Review
253 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2026, worth a combined $3.16B — down 4.8% from $3.32B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new IDYA positions and 32 closed out — a net gain of 13 holders — while 87 added to existing stakes and 75 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $20.4M. The largest seller was Point72 Asset Management, cutting an estimated $50.9M.
- 253 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2026, up from 246 in Q4 2025.
- Funds reported $3.16B of IDEAYA Biosciences stock for Q1 2026, down 4.8% quarter-over-quarter.
- 45 funds opened new IDEAYA Biosciences positions in Q1 2026 and 32 closed out, a net change of +13 holders.
- The largest IDEAYA Biosciences buyer in Q1 2026 was Morgan Stanley, an estimated $20.4M added.
- The largest IDEAYA Biosciences seller in Q1 2026 was Point72 Asset Management, an estimated $50.9M sold.
Based on aggregated 13F filings for Q1 2026.